Tatva Chintan Pharma Chem Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the FY 2024-25'.
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem has filed its Business Responsibility and Sustainability Report (BRSR) for FY 2024-25, as required by SEBI regulations. The company is a specialty chemicals manufacturer with FY25 turnover of ₹3,664.15 million and net worth of ₹7,213.12 million, operating two plants in Gujarat (Dahej and Ankleshwar) and exporting to 34 countries (59.82% of revenue). Product mix is led by Pharmaceutical & Agrochemical Intermediates (34.31%), Structure Directing Agents (33.66%), and Phase Transfer Catalysts (30.09%). On ESG, the company achieved an average of 20 EHS training hours per employee (target 16), sourced 62.73% of raw materials sustainably, and increased environmental/social capex to 7.81% (from 1.41%). However, the company paid a ₹450,000 fine to the Gujarat Pollution Control Board for Water Act violations. Zero workplace fatalities or safety incidents were recorded.
This is a routine regulatory disclosure that gives shareholders visibility into the company's ESG practices, targets, and compliance status. The improved sustainability capex and zero-fatality record are positives, while the ₹4.5 lakh pollution fine, though small in scale, signals ongoing environmental compliance risks. No material change expected in stock price from this disclosure alone.